GOP super PAC pauses spending in North Carolina Senate race, shifting money to Kansas

A top Republican super PAC is pausing its ad spending in the Senate race in North Carolina and launching a new ad effort in Kansas, the latest sign the fight for the majority is shifting to red states amid an increasingly tough landscape for the GOP.The new moves from the Senate Leadership Fund, a super PAC aligned with Senate GOP leadership, were first reported by Semafor and confirmed by two people with knowledge of the decision.Ad spending decisions can provide clear signals about the races parties and outside groups view as the most competitive and further out of reach.
SLF’s move to direct resources to Kansas underscores how Democrats are putting traditionally Republican states in play as they try to net four seats to take control of the Senate.Democrats will need to win multiple states President Donald Trump won by double digits in 2024, in addition to defending seats in battleground states.As Election Day draws closer, Democrats are growing more optimistic about their chances as Trump’s approval ratings drop and voters express frustrations with high costs and the Iran war.The race in Kansas between GOP Sen.
Roger Marshall and Democratic pastor Adam Hamilton has become more competitive in the homestretch, even though the state has not sent a Democrat to the Senate since 1932.GOP Sen.
Roger Marshall is in a tighter re-election race than expected in Kansas.Eric Lee / Getty SLF had been actively involved in North Carolina, where former Republican National Committee Chairman Michael Whatley is facing former Gov.Roy Cooper, a Democrat.
In September, the group spent more than $17 million on the race, according to the ad-tracking firm AdImpact.The group still has another $19 million in ads booked through Election Day but now has no plans to add to that.
For SubscribersFOR SUBSCRIBERSA sluggish Congress punts a long list of tasks until after the electionFOR SUBSCRIBERSIt’s rarely been harder for people to find new jobsFOR SUBSCRIBERS‘Some of the medicatio...